GVS advice for cladribine (Mavenclad®) – extension of further conditions
van der Waal JM, Wijma S
Record ID 32018002698
Dutch
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2021/07/05/extension-of-further-conditions-for-cladribine-mavenclad
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
The Netherlands
MeSH Terms
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Cladribine
- Immunosuppressive Agents
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.